Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Income from Continuing Operations (2020 - 2026)

Cytek Biosciences filings provide 6 years of Income from Continuing Operations readings, the most recent being 44076000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 558.98% to 44076000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 66486000.0, a 992.98% decrease, with the full-year FY2025 number at 66539000.0, down 1005.3% from a year prior.
  • Income from Continuing Operations hit 44076000.0 in Q4 2025 for Cytek Biosciences, down from 5469000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 9603000.0 in Q4 2024 to a low of 44076000.0 in Q4 2025.
  • Median Income from Continuing Operations over the past 5 years was 1661500.0 (2021), compared with a mean of 3962300.0.
  • The widest YoY moves for Income from Continuing Operations: up 419.14% in 2022, down 2215.69% in 2022.
  • Cytek Biosciences' Income from Continuing Operations stood at 1165000.0 in 2021, then soared by 419.14% to 3718000.0 in 2022, then skyrocketed by 48.01% to 5503000.0 in 2023, then soared by 74.5% to 9603000.0 in 2024, then tumbled by 558.98% to 44076000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 44076000.0 (Q4 2025), 5469000.0 (Q3 2025), and 5575000.0 (Q2 2025) per Business Quant data.